CoChat
Sign Up
Cited by 1,362Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic TumorsElectrolyte and hormonal disorders

Diagnosis and complications of Cushing’s syndrome: a consensus statement

Open access
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W. +12 more·2003·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2003-030871
Open this paper in CoChat — free account

Abstract

In October 2002, a workshop was held in Ancona, Italy, to reach a Consensus on the management of Cushing's syndrome. The workshop was organized by the University of Ancona and sponsored by the Pituitary Society, the European Neuroendocrine Association, and the Italian Society of Endocrinology. Invited international participants included almost 50 leading endocrinologists with specific expertise in the management of Cushing's syndrome. The consensus statement on diagnostic criteria and the diagnosis and treatment of complications of this syndrome reached at the workshop is hereby summarized.

Integrity signals

Registry

Crossref · 10.1210/jc.2003-030871

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Controlling hypercortisolism is the first step toward improving glucose metabolism in endogenous Cushing syndrome, but different treatments may affect diabetes outcome regardless of how well cortisol excess is corrected.

    “Controlling hypercortisolism is the first step toward improving glucose metabolism in patients with endogenous CS, but different treatments for hypercortisolism may affect the outcome of diabetes, regardless of how well cortisol excess is corrected (, , , , , , ).”

    From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [1]

  • Low-dose dexamethasone suppression testing has been used to diagnose subclinical hypercortisolism without advantages, except possibly in patients with alcoholism, psychiatric disorders, or diabetes.

    “Similarly, LDDST has been used to diagnose SH (18,40,41,55) without advantages, with the exception of patients affected with alcoholism, psychiatric disorders, and diabetes in whom this test may be more accurate (1,14,66).”

    From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [66]

  • Higher dexamethasone doses of 3 or 8 mg did not show better performance for diagnosing subclinical hypercortisolism.

    “some authors have proposed higher (3 or 8 mg) dexamethasone doses (40,46,54,56), which however did not show a better performance (14,23,66).”

    From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [66]

  • ACTH levels above 20 pg/ml or below 10 pg/ml suggest an ACTH-dependent or ACTH-independent cause of subclinical hypercortisolism, respectively.

    “In particular, ACTH levels above 20 pg/ml (4.4 pmol/liter) or below 10 pg/ml (2.2 pmol/liter) suggest an ACTH-dependent or -independent cause of SH, respectively (66).”

    From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [66]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., Kola, B., Lacroix, A., Mancini, T., Mantero, F., Newell-Price, J., Nieman, L. K., Sonino, N., Vance, M. L., Giustina, A., & Boscaro, M.
Affiliations
  • Azienda Ospedaliero-Universitaria delle Marche (IT)
  • University of Turin (IT)
  • Royal Victoria Hospital (GB)
  • Inserm (FR)
  • University of Milan (IT)
  • National Institutes of Health (US)
  • University of Bologna (IT)
  • Aurora St. Luke's Medical Center (US)
  • St Bartholomew's Hospital (GB)
  • Centre Hospitalier de l’Université de Montréal (CA)
  • University of Padua (IT)
  • Northern General Hospital (GB)
  • University of Virginia Health System (US)
  • University of Brescia (IT)
Corresponding author
Arnaldi, G.
ORCID
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2003-12
Volume
88
Issue
12
Pages
5593-5602
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
DOI
10.1210/jc.2003-030871
OpenAlex
W2061962280
Cited by
1,362
References
84
Citations by year
2026: 26 · 2025: 35 · 2024: 32 · 2023: 41 · 2022: 62 · 2021: 51 · 2020: 103 · 2019: 58 · 2018: 42 · 2017: 55 · 2016: 54 · 2015: 73 · 2014: 74 · 2013: 71 · 2012: 69
FWCI
26.31
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Electrolyte and hormonal disorders
Keywords
Cushing's syndrome, diagnostic criteria, hypercortisolism, complication treatment, consensus statement
MeSH terms
Mental Disorders, Cardiovascular Diseases, Cognition Disorders, Cushing Syndrome, Diagnosis, Differential, Humans, Osteoporosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review